Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2005-11-21
pubmed:abstractText
A potent DNA vaccine against HIV, combining a vector that takes advantage of the segregation and compartmentalization effect of bovine papilloma virus E2 protein with MultiHIV insert, expressing a fusion gene coding for the non-structural and structural proteins was developed and tested for immunogenicity in mice and humans.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/AIDS Vaccines, http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, nef, http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, rev, http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, tat, http://linkedlifedata.com/resource/pubmed/chemical/HIV Antibodies, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, DNA, http://linkedlifedata.com/resource/pubmed/chemical/Viral Nonstructural Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Viral Structural Proteins, http://linkedlifedata.com/resource/pubmed/chemical/nef Gene Products, Human..., http://linkedlifedata.com/resource/pubmed/chemical/rev Gene Products, Human..., http://linkedlifedata.com/resource/pubmed/chemical/tat Gene Products, Human...
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1286-4579
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1405-13
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16257560-AIDS Vaccines, pubmed-meshheading:16257560-Animals, pubmed-meshheading:16257560-CD8-Positive T-Lymphocytes, pubmed-meshheading:16257560-Clinical Trials, Phase I as Topic, pubmed-meshheading:16257560-Clinical Trials, Phase II as Topic, pubmed-meshheading:16257560-Consensus Sequence, pubmed-meshheading:16257560-Disease Models, Animal, pubmed-meshheading:16257560-Epitopes, pubmed-meshheading:16257560-Gene Products, nef, pubmed-meshheading:16257560-Gene Products, rev, pubmed-meshheading:16257560-Gene Products, tat, pubmed-meshheading:16257560-Genetic Vectors, pubmed-meshheading:16257560-HIV Antibodies, pubmed-meshheading:16257560-HIV Infections, pubmed-meshheading:16257560-HIV-1, pubmed-meshheading:16257560-Humans, pubmed-meshheading:16257560-Mice, pubmed-meshheading:16257560-Mice, Inbred BALB C, pubmed-meshheading:16257560-Models, Animal, pubmed-meshheading:16257560-Recombinant Fusion Proteins, pubmed-meshheading:16257560-Vaccines, DNA, pubmed-meshheading:16257560-Viral Nonstructural Proteins, pubmed-meshheading:16257560-Viral Structural Proteins, pubmed-meshheading:16257560-nef Gene Products, Human Immunodeficiency Virus, pubmed-meshheading:16257560-rev Gene Products, Human Immunodeficiency Virus, pubmed-meshheading:16257560-tat Gene Products, Human Immunodeficiency Virus
pubmed:year
2005
pubmed:articleTitle
A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studies.
pubmed:affiliation
Institute of Medical Technology, University of Tampere, Biokatu 8, 33520 Tampere, Finland. kai.krohn@uta.fi
pubmed:publicationType
Journal Article